https://orcid.org/0000-0003-2403-3336
References
- Ghiculescu RA. Therapeutic drug monitoring: which drugs, why, when and how to do it. Aust Prescriber. 2008. doi:10.18773/austprescr.2008.025
- Lucas C, Donovan P. Just a repeat”: when drug monitoring is indicated. Aust Fam Physician. 2013;42:18–22.
- Gross AS. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol. 1998;46:95–99. doi:10.1046/j.1365-2125.1998.00770.x
- Bayer WH. Therapeutic drug monitoring Clinical Guide. West J Med. 2008.
- C. KN, Touw DJ. Therapeutic drug monitoring, a practical application. Basic Clin Pharmacol Toxicol. 2010.
- Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs - Best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008.
- Mordasini MR, Krähenbühl S, Schlieger RG. Appropriateness of digoxin level monitoring. Swiss Med Wkly. 2002;132:506–512.
- Pennell PB. The role of therapeutic drug monitoring in patient care. Adv Stud Med. 2004.
- Selesky M, Spiehler V, Cravey RH, Elliot HW. Digoxin Concentrations in Fatal Cases. J Forensic Sci. 1977;22:10603J. doi:10.1520/JFS10603J
- Brodie MJ, Feely J. Practical clinical pharmacology. Therapeutic drug monitoring and clinical trials. Br Med J. 1988;296(6629):1110–1114. doi:10.1136/bmj.296.6629.1110
- Watson I, Thomson A. The value of therapeutic drug monitoring to the practising physician‐ an hypothesis needing sensible application. Br J Clin Pharmacol. 1989;28:619–620. doi:10.1111/j.1365-2125.1989.tb03553.x
- Bates DW, Soldin SJ, Rainey PM, Micelli JN. Strategies for physician education in therapeutic drug monitoring. Clin Chem. 1998;44:401–407. doi:10.1093/clinchem/44.2.401
- Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education - 2012. Am J Health-System Pharm. 2013;70:787–803. doi:10.2146/ajhp120777
- Alomi YA, Elshenawy RA. National survey of the pharmacokinetics services at Ministry of Health Hospitals in Saudi Arabia: pharmacy management practice. Int J Pharmacol Clin Sci. 2019.
- Fink A. How to Design Survey Studies; 2011.
- Jackson CFA. Best practice in survey design within health professions. London John Wiley; 2000.
- Watkins MW. Determining parallel analysis criteria. J Mod Appl Stat Methods. 2006.
- Kim J, Mueller CW. Introduction to factor analysis: what it is and how to do it sage University papers series. Quantitative applications in the social sciences. Quant Appl Soc Sci. 1978.
- Afifi AA, Clark V. Computer aided multivariate analysis lifetime learning publications belmont. California; 1984.
- Watson R, Thompson DR. Use of factor analysis in Journal of Advanced Nursing: literature review. J Adv Nurs. 2006;55:330–341. doi:10.1111/j.1365-2648.2006.03915.x
- Hayton JC, Allen DG, Scarpello V. Factor retention decisions in exploratory factor analysis: a tutorial on parallel analysis. Organizational Res Methods. 2004;7:191–205. doi:10.1177/1094428104263675
- Ferguson E, Cox T. Exploratory factor analysis: a users’ guide. Int J Sel Assess. 1993;1:84–94. doi:10.1111/j.1468-2389.1993.tb00092.x
- Martin Bland J, Altman DG. Statistics notes: cronbach’s alpha. Gen Pract. 1997;314.
- Cronbach LJ, Shavelson RJ. My Current Thoughts on Coefficient Alpha and Successor Procedures. Educ Psychol Meas. 2004;64:391–418. doi:10.1177/0013164404266386
- Costello AB, Osborne JW. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval. 2005.
- Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39:31–36. doi:10.1007/BF02291575
- Macefield R. Usability studies and the hawthorne effect. Journal of usability studies. 2007;2(3):145–154.
- Abou-Auda HS. Information-seeking behaviors and attitudes of physicians toward drug information centers in Saudi Arabia. Saudi Med J. 2008;29:107–115.